Register for upcoming Alpha QC User Groups
18/03/2026
Following the success of our first event dedicated to the quality control of alpha therapeutics, we will be hosting user groups at SNMMI and EANM
Targeted Alpha Therapies promise to deliver groundbreaking new treatments for cancers and other critical illnesses. LabLogic is leading the way in establishing quality controls prior to administration for these complex isotopes.
At our first Alpha QC User Group held at LabLogic’s headquarters, we brought together partners from across industry and academia to help drive innovation in this important area. Following its success, we will be hosting more user groups at the biggest events in radiopharmacy and nuclear medicine.
What we’ll cover
- The ongoing development of 225Ac, 212Pb and 211At in Targeted Alpha Therapies
- Current research into delivering practical QC solutions
- Live demonstrations of radio-TLC and radio-HPLC tests
- Presentations from industry partners
Register your interest
SNMMI | Los Angeles | Saturday 30 May, 2026
EANM | Vienna | Saturday 17 October, 2026